Summary - DRTS - NASDAQ - Weiss Ratings

Production (Stage)

D

Alpha Tau Medical Ltd. DRTS

$3.00 $0.000.00% NASDAQ

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$1.75 - $4.39

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT) and Alpha Tau Medical Ltd (DRTS)

5/22/2025 - TipRanks Financial Blog

Piper Sandler Sticks to Their Buy Rating for Alpha Tau Medical Ltd (DRTS)

5/20/2025 - TipRanks Financial Blog

Alpha Tau Medical Reports Q1 2025 Results and Major Clinical Advances

5/19/2025 - TipRanks Financial Blog

Alpha Tau Medical GAAP EPS of -$0.11

5/19/2025 - Seeking Alpha - Israel Stocks

Alpha Tau Announces First Quarter 2025 Financial Results and Provides Corporate Update

5/19/2025 - Globe Newswire

Alpha Tau Medical (DRTS) Projected to Post Quarterly Earnings on Monday

5/13/2025 - MarketBeat

Alpha Tau Announces Appointment of Nadav Kidron to its Board of Directors

5/12/2025 - Globe Newswire

Alpha Tau Medical And 2 Other Penny Stocks Worth Your Attention

5/8/2025 - Simply Wall St

Alpha Tau to Participate in May Investor Conferences

5/6/2025 - Globe Newswire

HC Wainwright Issues Positive Estimate for DRTS Earnings

5/3/2025 - MarketBeat

Alpha Tau Medical's (DRTS) "Buy" Rating Reaffirmed at HC Wainwright

5/1/2025 - MarketBeat

Alpha Tau Medical (DRTS) Secures $36.9M in Direct Offering with Oramed Pharmaceuticals DRTS ...

4/28/2025 - GuruFocus

Alpha Tau Medical (DRTS) Secures $36.9M in Strategic Stock Sale DRTS Stock News

4/28/2025 - GuruFocus

Oramed Pharmaceuticals invests $36.9 M in Alpha Tau Medical

4/28/2025 - SeekingAlpha.com: All News

Oramed Pharmaceuticals invests $36.9 M in Alpha Tau Medical

4/28/2025 - Seeking Alpha - Healthcare

Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals

4/28/2025 - Globe Newswire

Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical

4/28/2025 - PR Newswire

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

4/2/2025 - Globe Newswire

Alpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 60.7% in March

3/30/2025 - MarketBeat

Citi Sticks to Their Buy Rating for Alpha Tau Medical Ltd (DRTS)

3/21/2025 - TipRanks Financial Blog

HC Wainwright Expects Reduced Earnings for Alpha Tau Medical

3/20/2025 - MarketBeat

Alpha Tau Medical (NASDAQ:DRTS) Given Buy Rating at HC Wainwright

3/18/2025 - MarketBeat

Sidoti Events, LLC's Virtual March Small-Cap Conference

3/18/2025 - Accesswire

Alpha Tau Medical (NASDAQ:DRTS) Announces Earnings Results

3/13/2025 - MarketBeat

Alpha Tau Medical Reports 2024 Financial Results and Advances in Cancer Therapy Trials

3/12/2025 - TipRanks Financial Blog

Income Statement

Total Revenue (TTM)

--

EBITDA (TTM)

--

EBIT (TTM)

--

Net Income (TTM)

--

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

--

Cash from Investing (TTM)

--

Cash from Financing (TTM)

--

Net Change in Cash (TTM)

--

Filings

Filing Date

Wednesday, March 12, 2025

Period Date

Tuesday, December 31, 2024

Next Filing

Week of May 19 and 23 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

--

52-week Low

Jun 27, 2024 - $1.75

52-week High

Jan 27, 2025 - $4.39

Valuation

Market Cap

$254.10M - Micro Cap

Enterprise Value

Price/Sales (TTM)

--

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

www.alphatau.com

Phone Number

972 3 577 4115

Address

Kiryat HaMada St. 5
Jerusalem, 9777605

Country

Year Founded

--

Business Description

Sector

Industry

Health Care Equipment and Services

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for... more